Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Independent Medical Education Funding

Notice of Independent Medical Education (IME) Process Change:

Amgen has changed its submission requirements by instituting application periods for all new IME requests. Please review the updated requirements and timeline under the IME Application Requirements section of our website. If you have any questions please email Amgen Healthcare Compliance at hccime@amgen.com

As part of Amgen's mission to further the advancement of medicine and healthcare, Amgen supports Independent Medical Education ("IME"). IME is professional education given by accredited medical education providers who design and implement programs totally independent of any Amgen influence, as defined by standards such as the Accreditation Council for Continuing Medical Education ("ACCME") guidelines, the FDA's Guidance: Industry Supported Scientific and Educational Activities, and the PhRMA Code.

Funding requests including for live presentations, written enduring materials, online courses, and conference symposia from organizations (e.g. hospitals, universities, societies, medical-education vendors) will be reviewed and assessed in conjunction with Amgen's goal to help physicians and other healthcare professionals to obtain information and insights that contribute to the improvement of patient care and the advancement of medicine.

Areas of Interest to Amgen

Click to Expand

Biomedical Data Sciences


  • Biosimilar approval pathway
  • Biologic manufacturing and biosimilar development
  • Policy questions related to biosimilars including naming and interchangeability


  • Burden of disease and clinical consequences of osteoporotic fractures
  • Improving awareness, diagnosis and treatment of osteoporosis
  • Urgency to treat post fragility fracture – secondary fracture prevention
  • Identifying patients with osteoporosis at high risk for fracture


  • Dyslipidemia Research - Cardiovascular risk; Role of PCSK9
  • Atherosclerosis
  • Familial Hypercholesterolemia
  • Impact of Dyslipidemia on society
  • Heart Failure Research – Heart rate and Cardiovascular risk; biomarkers; response to treatment
  • Treatment, prognosis for patients, and unmet needs
  • Heart rate and Cardiovascular risk
  • Impact of Heart Failure on society


  • Hematologic malignancies (e.g. Acute Leukemia, Multiple Myeloma)
  • Bone metastases from solid tumors
  • Malignant Melanoma
  • Gastrointestinal cancers
  • Immune cytopenias
  • Biosimilar education
  • Supportive care, including addressing side effects of treatment


  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Ankylosing Spondylitis
  • Juvenile Idiopathic Arthritis
  • Dermatologic diseases with a focus on Psoriasis
  • Other inflammatory diseases including asthma and inflammatory bowel disease
  • Broader topics in immunology and autoimmunity


  • Dialysis
  • Chronic Kidney Disease (CKD)
  • Anemia
  • CKD Mineral and Bone Disorder
  • Emerging data (clinical and basic research)
  • Burden of disease and clinical consequences
  • Improving awareness, diagnosis and treatment
  • Identifying and monitoring measures of treatment success
  • Challenges in treating patients and optimizing patient/disease/practice management
  • Healthcare disparities


  • Neuropsychiatric research, education and training in the area of migraine


  • Advance field of Pharmacy
  • Professional development in:
    • Oncology
    • Hematology
    • Bone
    • Nephrology
    • Inflammation
    • Cardiology
    • Biosimilars

Translational Sciences

  • Comparative Biology and Safety Sciences
  • Medical Sciences
  • Pharmacokinetics and Drug Metabolism
  • Process and product development
  • Advance field of Translational Sciences focusing on new areas for professional development
  • Education and training of students through didactic and experiential opportunities

Overview of IME Funding Application Process

Amgen is dedicated to making the application process simple and straightforward. Amgen will send an email confirmation upon receipt of your application and documentation.

IME Application Requirements

Amgen's IME funding application process includes:

    Requests for Independent Medical Education funding must be submitted according to the schedule below:

    Application Period Decision Communicated: Start date of Program/Activity*
    October 5, 2015 – November 6, 2015 No later than 45 days prior to the program start date January  1, 2016– June 30, 2016
    February 15, 2016 – April 1, 2016 No later than 45 days prior to the program start date July 1, 2016 – December 31, 2016

    * Amgen requires that an agreement is fully executed prior to the start date of the program content development or activity. Please plan ahead to ensure the decision and contract execution can be completed to meet your deadline.

  • Requests that are received after an application period has closed will not be considered and will need to be resubmitted during the next application period if the start date for the program qualifies. 
  • Attachment of the following required documents (in .pdf format) to the application:
    • Letter of Request on the requesting organization's letterhead which includes the following:
      • Must be addressed to Amgen
      • Signed and Dated
      • Program title, date(s), and location(s)
      • Description of the proposed activity
      • Identification of the target audience and projected number of attendees
      • Name of accrediting body and accredited provider, including type and number of medical education credits offered for the proposed activity (program MUST be accredited)
      • If applicable, identification of co-requesting organization(s), medical education partner(s), and/or logistical partner. Please include contact information for these organizations.
    • Needs Assessment (can be included in the Letter of Request)
    • Educational Objectives (can be included in the Letter of Request)
    • Agenda (draft acceptable)
    • Full Program Budget
    • Amgen/ Requested Amount Budget
      (Please Note: Amgen does not prohibit organizers from serving meals at IME events; however, Amgen's IME funds cannot be used to provide meals at IME events)
    • Current IRS W9 form (must be signed and dated within the last 12 months)

Please note that submitting a request does not guarantee you and/or your organization will receive IME funding.

Eligibility Criteria - Important Application Considerations

Independent Medical Education supported by Amgen in the U.S. MUST be:

  • Provided by a United States based accredited provider (e.g. ACCME, ACPE, ANCC) or other organizations authorized by state law to award continuing medical education credits.
  • Paid to a United States based organization

It is important to note:

  • Amgen will not provide IME funding for:
    • Individuals
    • Requests for payments to Individuals
    • Fellowships
    • Overhead Expenses
    • General Operating Expenses
    • Entertainment Expenses
    • Awards/ Travel Awards
    • Costs of travel, lodging, or other personal expenses of non-faculty individuals attending IME, either directly to the individuals participating in the event or indirectly to the event's provider. Funding cannot be used to compensate participants for time spent at the IME event.
    • Meals
      • Amgen does not prohibit organizers from serving meals at IME events; however, Amgen's IME funds shall not be used to provide meals at IME events.
  • Amgen's support for IME programs that meet the Eligibility Criteria is compliant with federal and state laws, as well as guidelines that govern such activities.
  • Amgen commercial staff, including field staff, is not involved in decisions to fund IME programs. For more information regarding Amgen's interactions with healthcare professionals and other customers, (click here).
  • Responsibility and control over the selection, content, faculty, educational methods, materials, and venue for an independent medical education event belongs solely to the organizers of the event in accordance with the accredited provider's guidelines. Amgen will not provide any advice or guidance to the accredited independent medical education provider (even if asked) regarding the content or faculty for any Independent Medical Education program.
  • IME funding decisions will not take into account the current or potential customer status of the IME requestor.
  • Amgen requires that a fully-executed agreement, signed by the requesting IME Provider and Amgen be completed prior to the commencement of the IME program.
  • For funding requests approved by Amgen, the IME funding recipient is required to confirm the completion of the activity and provide documentation of how the funds were used within 60 days after the completion of the independent medical education activity. Documentation should be sent to hccime@amgen.com for reconciliation.

Please note that submitting a request does not guarantee you and/or your organization will receive IME funding.